Neuroplasticity

Boston, Massachusetts, U.S., September 15, 2026 ReEmerge, Inc. has emerged from stealth with an oversubscribed $37 million Series A...

BARCELONA, Spain — September 10, 2026 CONNECTA Therapeutics announced the closing of a €3.1 million financing led by new...

PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...

AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...

VAN NUYS, Calif., August 18, 2026 Kandu, Inc. announced the publication of results from BCI-REHAB, the first randomized controlled...

CAMBRIDGE, Mass., Aug. 14, 2026 Enveric Biosciences reported continued progress in the preclinical development of EB-003, its lead next-generation...

GENEVA, Switzerland, July 9, 2026 MindMaze Therapeutics Holding SA has announced its support for a University of Pittsburgh clinical...

VALENCIA, Calif., June 29, 2026 Bioness Medical, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

BARCELONA, Spain, June 10, 2026 CONNECTA Therapeutics announced the initiation of a Phase IIa clinical trial evaluating CTH120, its...